0.00TWD
803.00 KTWD
648.63 MTWD
56.49 M
About UBI PHARMA INC
Sector
CEO
Chi Hsiang Chen
Headquarters
Hsinchu
Website
Founded
2014
ISIN
TW0006562002
FIGI
BBG00BWD1C30
UBI Pharma, Inc. engages in the research, development, manufacture and sale of non-antibody protein drugs, small molecule new drugs and special medicine. Its products include Ubixa film coated tablets, levetiracetam concentrate solution, and lamivudine film coated tablets. It also provides commissioned drug manufacturing and technical services. The company was founded by Yi Cheng Wang on July 31, 2014 and is headquartered in Hsinchu, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6562 is 15.85 TWD — it has increased by 15.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange UBI PHARMA INC stocks are traded under the ticker 6562.
6562 stock is 28.09% volatile and has beta coefficient of 0.97. Check out the list of the most volatile stocks — is UBI PHARMA INC there?
Yes, you can track UBI PHARMA INC financials in yearly and quarterly reports right on TradingView.
6562 stock has fallen by 40.53% compared to the previous week, the month change is a 45.81% fall, over the last year UBI PHARMA INC has showed a 61.65% decrease.
6562 net income for the last quarter is −13.04 M TWD, while the quarter before that showed 13.84 M TWD of net income which accounts for −194.20% change. Track more UBI PHARMA INC financial stats to get the full picture.
Today UBI PHARMA INC has the market capitalization of 1.62 B, it has decreased by 41.30% over the last week.
No, 6562 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6562 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UBI PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UBI PHARMA INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UBI PHARMA INC stock shows the strong sell signal. See more of UBI PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UBI PHARMA INC EBITDA is 96.85 M TWD, and current EBITDA margin is 14.93%. See more stats in UBI PHARMA INC financial statements.